Marpai, Inc. (NASDAQ:MRAI – Get Rating) was up 8.8% during mid-day trading on Wednesday . The company traded as high as $0.96 and last traded at $0.96. Approximately 2,953 shares were traded during trading, a decline of 77% from the average daily volume of 12,747 shares. The stock had previously closed at $0.88.
Marpai Trading Up 8.8 %
The company has a market capitalization of $20.40 million, a P/E ratio of -0.77 and a beta of 0.39. The business's fifty day moving average price is $0.89 and its 200-day moving average price is $0.93.
Get Marpai alerts:Marpai (NASDAQ:MRAI – Get Rating) last posted its quarterly earnings data on Wednesday, November 9th. The company reported ($0.28) earnings per share (EPS) for the quarter. Marpai had a negative return on equity of 108.51% and a negative net margin of 104.66%. The company had revenue of $4.94 million for the quarter.
Hedge Funds Weigh In On Marpai
An institutional investor recently bought a new position in Marpai stock. Jane Street Group LLC acquired a new position in shares of Marpai, Inc. (NASDAQ:MRAI – Get Rating) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 15,586 shares of the company's stock, valued at approximately $28,000. Jane Street Group LLC owned approximately 0.08% of Marpai at the end of the most recent reporting period. 35.90% of the stock is owned by hedge funds and other institutional investors.Marpai Company Profile
(Get Rating)
Marpai, Inc, a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services.
Featured Articles
- Get a free copy of the StockNews.com research report on Marpai (MRAI)
- AMD Is Still One Of The Best Semiconductor Stocks Out There
- Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
- Is The Bottom In For Cyber-Security Stocks?
- Union Pacific, Norfolk Southern Pull into Buying Zone
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
Receive News & Ratings for Marpai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marpai and related companies with MarketBeat.com's FREE daily email newsletter.